ENDECE Neural (an ENDECE Company) is focused on developing drugs that regulate genes in signaling pathways involved in remyelinating damaged nerve axons. Our goal is to restore muscle control and mobility in MS patients.

Read More

Media & Press

 

 

Media & Press

Structurally similar estradiol analogs uniquely alter the regulation of intracellular signaling pathways

Read More

ENDECE Neural to Present Findings at 2013 Biotech Showcase on NDC-1308 which Induces Remyelination of Demyelinated Axons.

Read More

Read More